. . . . . . . . . . . . . "a(CHEBI:rosiglitazone) -> r(MGI:Cd36)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "As expected, we found that rosiglitazone, a TZD, strongly promotes TR4-induced CD36 transactivation (Fig. 6C). Similar induction was also found when we replaced TR4 with PPARgamma/RXR (Fig. 6C)." . . "Selventa" . . . . "2014-07-03T14:33:36.080+02:00"^^ . . .